The 4,000-year-old drug, most commonly used to treat pain, prevents certain tumours from forming and spreading across the body – findings that are already changing health policies.

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...

Research in mice shows how aspirin may boost the immune response against cancer, keeping secondary tumors at bay. Image credit: AsiaVision/Getty Images. According to Cancer Research UK, half of all ...

A daily regimen of low dose aspirin probably does not significantly reduce the risk of colorectal cancer but may increase the risk of bleeding in the brain area, according to a large-scale analysis of ...

One of aspirin’s most intriguing properties is its anti-cancer activity. A Swedish research study published in the New England Journal of Medicine (Sept. 18, 2025) concludes that aspirin can ...

Recent research from Massachusetts General Hospital and Harvard Medical School has uncovered aspirin‘s surprising protective effect against colorectal cancer, particularly among individuals with less ...

The hypothesis that low-dose aspirin might eventually lower cancer risk after years of use appears unsupported in adults aged 70 years or older, according to new long-term data from the ASPREE trial.

Aspirin is often touted as the wonder drug of the 20th century. Famous for its versatility—easing aches and pains, reducing fever and inflammation, preventing heart attacks and stroke—experts have ...

One of aspirin’s most intriguing properties is its anti-cancer activity. A Swedish research study published in the New England Journal of Medicine (Sept. 18, 2025) concludes that aspirin can ...